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Cytotoxic Cell Granule-Mediated Apoptosis: Perforin
Delivers Granzyme B-Serglycin Complexes into
Target Cells without Plasma Membrane Pore Formation
the plasma membrane (Young et al., 1986). Although
appealing, experimental evidence for this model is mar-
ginal, leaving the mechanism underlying PFN-depen-
dent delivery of the granzymes unexplained. We have
previously demonstrated that GrB binds to target cells
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Australia nally proposed by the Podack laboratory (Podack et
al., 1988), we predicted that PFN pores in the plasma
membrane would undergo internalization with bound
granzyme to an endocytic vesicle where the establishedSummary
channels then facilitate escape of the protease (Froelich
et al., 1998). Contrary to this prediction, we show hereThe mechanism underlying perforin (PFN)-dependent
delivery of apoptotic granzymes during cytotoxic cell that cells that are destined to become apoptotic after
exposure to PFN and GrB do not possess detectablegranule-mediated death remains speculative. Gran-
zyme B (GrB) and perforin were found to coexist as plasma membrane pores.
Complementing our observations of PFN-mediatedmultimeric complexes with the proteoglycan serglycin
(SG) in cytotoxic granules, and cytotoxic cells were delivery, evidence is also presented that serglycin (SG),
the primary proteoglycan of cytotoxic granules, plays aobserved to secrete exclusively macromolecular GrB-
SG. Contrary to the view that PFN acts as a gateway central role in granule-mediated apoptosis. SG, distin-
guished by linkage of chondroitin sulfate (CS) glycos-for granzymes through the plasma membrane, mono-
meric PFN and, strikingly, PFN-SG complexes were aminoglycans (GAG) to Ser-Gly repeats in the central
portion of the core protein (Stevens et al., 1988), report-shown to mediate cytosolic delivery of macromolec-
ular GrB-SG without producing detectable plasma edly facilitates packaging of proteases and cytokines
and is postulated to participate in their transport to ex-membrane pores. These results indicate that granule-
mediated apoptosis represents a phenomenon whereby tracellular sites (Stevens et al., 1988; Matsumoto et al.,
1995). We show here that GrB is secreted solely in athe target cell perceives granule contents as a multi-
meric complex consisting of SG, PFN, and granzymes, macromolecular form bound to SG and preformed GrB-
SG complexes are delivered by PFN to induce apoptosiswhich are, respectively, the scaffold, translocator, and
targeting/informational components of this modular through a process that does not involve detectable
plasma membrane permeabilization. Furthermore, PFNdelivery system.
retains the capacity to deliver the macromolecular gran-
zyme complex when ionically linked to SG. The resultsIntroduction
suggest that PFN, either in monomeric form or com-
plexed to SG, enters the target cell delivering internal-The ability of cytotoxic lymphocytes to initiate apoptosis
in pathogen-infected and transformed cells depends on ized macromolecular granzyme complex from a vesicu-
lar compartment in a manner similar to viral-mediatedtwo fundamentally distinct signal transduction strate-
gies. Through a series of complex molecular interac- cellular penetration.
tions, the Fas pathway involves receptor-dependent
transmission of signals that activates the death cas- Results
pases and other host responses. The granule secretion
pathway, on the other hand, appears to require the direct Transmembrane Pores Formed by Sublytic PFN
intracellular delivery of a family of granule-associated- Is a Constrained Outcome
serine proteases, which activate both caspase-indepen- Experimental models of GrB-induced cell death involve
dent (granzyme A, GrA) and dependent (granzyme B, the addition of isolated PFN to target cells in “sublytic”
GrB) death programs to ensure that the targeted cell quantities that irreversibly damage a minority of the tar-
dies. Perforin (PFN), well-known for its pore-forming ca- get cells (5%–20%) when evaluated microscopically. It
pacity, has long been considered the vehicle that pro- has been assumed that the remaining viable targets also
vides the gateway for entry of the granzymes through undergo membrane damage but the pores are elimi-
nated by exocytic or endocytic processes. To document
the dynamics of membrane permeabilization produced5 Correspondence: c-froelich@northwestern.edu
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Figure 1. Inability to Detect PFN-Mediated
Plasma Membrane Perforations in Cells Un-
dergoing Apoptosis
(A) Isolated PFN leads to rapid appearance of
a stable subset of permeabilized cells. Jurkat
cells were preincubated with PI for 10 min
(37C), followed by treatment with PFN at indi-
cated concentrations. Aliquots were ana-
lyzed at indicated times with a FACScalibur
instrument, and the number of PI positive
cells (permeabilized) was enumerated. Re-
sults are representative of three separate ex-
periments.
(B) PFN delivers GrB in 0.2 mM Ca buffer
without plasma membrane permeabilization.
Jurkat cells were treated with PFN at indi-
cated concentrations for 30 min (37C), and
the percent of permeabilized cells was deter-
mined by trypan blue stain (inset). For the
apoptosis assay, cells were treated with a
combination of indicated PFN and GrB (1ug/
ml) for 4 hr under identical conditions, fixed,
and evaluated microscopically (Hoescht) and
flow cytometrically (TUNEL). Data for TUNEL
is shown (mean  SD, n  2) where Hoescht
stain produced similar results (data not
shown).
(C) Absence of membrane permeabilization
in cells undergoing apoptosis. Dot-plots of
Yopro-1 (FL-1, x axis) versus PI (FL-3, y axis)
fluorescence are shown. Cells were preincu-
bated with PI and Yopro-1 for 10 min (37C),
followed by PFN (30 ng/ml) and/or GrB (2 g/
ml) in high Ca buffer, and analyzed by flow
cytometry. Note: apoptotic cells that are
Yopro-1 exclude PI (lower right quadrant).
Results are representative of three experi-
ments.
by sublytic PFN, the generation and potential clearance volume. Viable cells that transiently expressed pores
should, on the other hand, be PI but maintain normalof membrane pores were evaluated in Jurkat cells
treated sequentially with propidium iodide (PI) and PFN volume. A population of cells with these characteristics
could not be identified. Furthermore, if a subset of tar-in the presence of extracellular calcium (1.5 mM). Iso-
lated PFN produced the rapid appearance of a stable gets transiently expressed pores, then the number of PI
positive cells should decrease as the time between thesubset of PI cells (Figure 1A). Measurement of light
scatter characteristics showed that PI cells possessed addition of PFN and PI was lengthened. We found that
the percentage of permeabilized cells was comparablereduced cell volume (data not shown). The shrunken
cells were viewed as dying, being unable to repair mem- whether the PI was added prior to PFN or 5–10 min
afterward (data not shown). Together the data indicatebrane damage (i.e., eliminate pores) and sustain normal
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that a sublytic dose of PFN rapidly permeabilizes a lim- The anti-GrB mAb precipitated a diffuse band consistent
with SG as determined by sensitivity to chondroitinaseited number of targets, leaving the majority unaffected.
GrB would, therefore, interact with two subsets: a per- ABC and resistance to heparinase/heparitinase diges-
tion (Figure 2A) plus comparison to the mobility of iso-meabilized population plus another which might un-
dergo apoptosis despite the absence of membrane lated SG by SDS-PAGE and silver stain (Figure 2A). Anti-
G9 PFN IP yielded a diffuse band consistent with SGalterations. This distinction is crucial because both sub-
sets could show signs of nuclear apoptosis due to but with lesser intensity, reflecting perhaps the lower
endogenous levels of the PFN in granules (Figure 2A).PFN-dependent delivery of granzyme B regardless of
the response to PFN exposure. In companion experiments designed to evaluate a trimo-
lecular interaction, IP with anti-GrB and anti-G9 PFNTo investigate whether GrB induced apoptosis in both
permeabilized and intact targets, two approaches were yielded PFN and GrB, respectively (Figures 2B and 2C).
The association of GrB, PFN, and SG was confirmed bytaken. First, cell death was evaluated under conditions
that would favor delivery of GrB by PFN yet absolutely subjecting the anti-G9 PFN immunoprecipitate to GrB
ELISA (Figure 2D), and the presence of the highly glyco-minimize plasma membrane permeabilization. Second,
membrane and nuclear alterations were evaluated si- sylated SG in the immunoprecipitate was validated by
the Blyscan assay, which quantitatively detects proteo-multaneously in targets undergoing PFN/GrB-induced
apoptosis. After identifying the minimum Ca2 concen- glycans (Figure 2D). Together the results are the first to
show a direct multimeric interaction between PFN, GrB,tration that supported delivery of GrB by PFN (0.2 mM),
we generated a broad concentration curve to determine and SG in granules of cytotoxic cells.
whether PFN permeabilized the target cells. For concen-
trations of PFN ranging from 25 to 500 ng/ml, the number GrB Is Exocytosed from Cytotoxic Cells
of permeabilized targets was comparable to media (Fig- in a Macromolecular Form
ure 1B, inset). PFN, nonetheless, produced a robust Since GrB appears to interact with SG in cytotoxic gran-
apoptotic response in the presence of GrB, providing ules (Figure 2A), the hypothesis was evaluated that the
indirect evidence that PFN has the capacity to deliver granzyme would be released as a macromolecular com-
the granzyme through a process that does not involve plex during stimulated secretion. Degranulate from 35S
plasma membrane pore formation (Figure 1B). Although biosynthetically labeled LAK cells was obtained by stim-
this correlative study appeared to exclude a role for ulation with anti-CD2 mAb as described (Galvin et al.,
plasma membrane pore formation in the delivery of the 1999). Complexed GrB was distinguished from the
granzyme, definitive proof required the simultaneous monomeric form by size exclusion membrane filtration,
evaluation of membrane and nuclear alterations in the followed by measurement of granzyme content in the
same target cell. This was achieved by adding the mem- two compartments (Figure 3A). SG was subsequently
brane impermeant nuclear dye, Yopro-1, and the plasma identified indirectly by IP of the retentate fraction with
membrane impermeant probe, PI, to the targets prior to anti-GrB mAb and digestion with chondroitinase ABC
incubation with PFN and GrB. The outcome was then (Figure 3B). These results establish that GrB is secreted
monitored by flow cytometry. Besides the predicted per- from cytotoxic cells only as a macromolecular complex
meabilized subset, the appearance of Yopro-1, PI with SG and that PFN would then have to deliver not
cells (Figure 1C) indicated that targets succumbing to merely the monomeric granzyme but a much larger moi-
GrB-induced apoptosis fail to display early evidence of ety (300 kDa) to effect cell death.
membrane damage. As the period of incubation length-
ens, the number of Yopro-1, PI cells declined and GrB-SG Complexes—Stability, Proteolytic Properties,
were replaced by apoptotic cells that developed sec- and Capacity to Induce Apoptosis
ondary membrane damage (Yopro-1, PI). PFN ap- after Intracellular Delivery
pears, therefore, to act through two distinct processes To learn whether we could reconstitute proapoptotic
after addition to suspended target cells: (1) very rapid granzyme complexes in vitro, the stability of a mixture
plasma membrane poration and (2) a process which of GrB and SG was evaluated under extracellular condi-
involves intracellular delivery of granule proteins without tions (Figure 4). Complexes were assembled by mixing
overt membrane perforation. It is noteworthy that the GrB with SG isolated from the monocytic cell line, THP-1,
concentration of PFN necessary for pore formation followed by size exclusion membrane filtration to re-
markedly exceeds values required for granzyme de- move monomeric granzyme. Using agarose gel electro-
livery. phoresis and combined toluidine blue and Coomassie
blue staining to detect the proteoglycan and protease,
respectively, we directly evaluated the molecular inter-Identification of PFN-GrB-SG Complexes
in Cytotoxic Granule Extracts action of the cationic granzyme and anionic SG. Com-
pared to a set of proteoglycan standards (aggrecan,To minimize the disruption of a cytotoxic granule, PFN
as well as the granzymes are postulated to be seques- 2.5	 106 kDa; biglycan,350 kDa; decorin,100 kDa;
CS, 30 kDa), SG, on the basis of mass and charge,tered by the granule-associated proteoglycan, serglycin
(MacDermott et al., 1985). To document the association migrated with the predicted Mr approximating 250–300
kDa, whereas the free granzyme shifted upward in theof these constituents, the interaction of PFN and GrB
with SG was evaluated by coimmunoprecipitation (IP). gel due to its cationic state. When the mobility of the
preformed complexes was examined, we failed to detectGranules from 35S-labeled YT cells were treated with
Zwittergent 3–12 (0.5%), the detergent providing optimal free GrB, and the SG band appeared to redistribute into
two components where the first was situated slightlysolubilization (data not shown), and IP was performed.
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Figure 2. GrB and PFN Are Associated with
SG in YT Cytotoxic Granules
(A) GrB and PFN associate with a highly sul-
fated macromolecule in cytotoxic granules.
Zwittergent solubilized, 35S-labeled YT gran-
ule extract was subjected to IP with antibod-
ies to GrB, PFN, or BSA as indicated, and the
material was run on 4%–15% gradient gels
followed by fluorography. Anti-GB10 immu-
noprecipitated material was subjected to
chondroitinase ABC, heparinase, or hepariti-
nase digestion as described. Isolated SG
(6.25 g) was electrophoresed and silver
stained for comparison.
(B and C) GrB and PFN form multimeric com-
plexes in cytotoxic granules. Solubilized cy-
totoxic granules were subjected to IP as de-
scribed followed by immunoblotting for PFN
(B) or GrB (C). Isolated PFN or GrB served as
controls in (B) and (C), respectively (lane 3).
In (B), Sepharose beads alone incubated with
solubilized granules served as control, and
an immunoprecipitating antibody for BSA
functioned similarly in (C). For (B) (lane 1),
bands immediately beneath nominal PFN re-
active band represent heavy chain for immu-
noprecipitating anti-GrB antibody. For (C),
doublet near 46 kDa marker is from nonspe-
cific staining of anti-GrB.
(D) Anti-GrB and anti-G9 PFN immunopre-
cipitates GAGs. Solubilized cytotoxic gran-
ules were subjected to IP with indicated anti-
bodies, and associated GrB and GAG content
was quantitated by ELISA and Blyscan assay,
respectively. Open bars represent GrB values
on a log scale, while gray bars represent total
GAG on linear scale (mean  SD, n  2).
above the band that migrated in a position similar to SG processed both caspases with less efficiency than the
free granzyme (Figure 4D). The apoptotic activity of GrB-alone (Figure 4A). The presence of the granzyme in the
redistributed SG bands was then verified by extracting SG was then evaluated using AD, the PFN substitute
we have previously described to deliver granzymes in-the protein from the agarose and performing an anti-
GrB immunoblot (Figure 4B). In addition to confirming tracellularly (Froelich et al., 1996a). Although GrB-SG
displayed a reduced capacity to process caspases-3that GrB forms a stable interaction with SG, these results
suggest that the granzyme forms multimeric complexes and -7 in vitro, GrB-SG delivered by AD produced a
greater concentration-dependent level of apoptosiswhere the stoichiometric ratio of GrB:SG exceeds 1:1.
Indeed, titration experiments indicate that as many as (Figure 4E). Finally and most notably, PFN was as effec-
tive as AD in delivering the macromolecular GrB-SG20 GrB molecules may interact with a single SG (data
not shown). Finally, complementary experiments were complexes into target cells through a process that did
not involve plasma membrane permeabilization of theperformed to ensure stable complexes after dilution with
the targets. Complexes were serially diluted 2-fold and cells undergoing apoptosis (Figure 4F).
membrane filtered. Using IETD-pNA, GrB activity re-
mained entirely in the retentate (data not shown). PFN-SG Complexes Deliver Macromolecular
GrB in the Absence of DemonstrableThe proteolytic activities of GrB-SG and free GrB were
then compared against two physiologically relevant Plasma Membrane Pores
Since PFN also appeared to interact with SG in secretorysubstrates, caspase-3 and -7 (Yang et al., 1998). Al-
though comparable molar quantities of GrB-SG and free granules, we asked whether the pore-forming protein
might also remain stably complexed to SG in vitro andGrB (determined by EIA) produced equivalent esterolytic
activities (BAADT assay, Figure 4C), GrB-SG complexes deliver the macromolecular granzyme complex. Conse-
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Figure 3. Granzyme B Is Secreted Exclusively in a High Mr Form from LAK Cells Coupled to SG
(A) GrB is exocytosed exclusively in a high Mr form. LAK cells were either untreated or induced to degranulate for 5 hr. Supernatants were
collected and subjected to 100 kDa filtration, and the amount of GrB in the various fractions was quantitated by ELISA. GrB levels were
normalized for volume and are representative from one of three normal donors. The filtrate fractions lacked detectable GrB.
(B) The high Mr form of secreted GrB is sensitive to chondroitinase ABC digestion. Degranulates from 35S-labeled LAK cells were filtered and
immunoprecipitated with anti-GrB. Samples were subjected to overnight endoglycosidase digestions (chondroitinase ABC, lane 2; heparinase,
lane 3; heparitinase, lane 4; left untreated, lane 1), followed by electrophoresis and phosphoimaging.
quently, it was crucial to ensure that the PFN-SG interac- ml, rapidly damages 50% of Jurkat (1 	 107/ml).
PFN-SG, on the other hand, is more than 5- to 10-foldtion was stable during contact with the target cell.
PFN-SG was formed by mixing SG and PFN (150 mM less potent (Figure 6A), indicating that the proteoglycan
does indeed suppress membranolytic activity. If plasmaNaCl [pH 7.4]) and subjecting the mixture to size exclu-
sion membrane filtration (100 kDa). By semiquantitative membrane pore formation is a prerequisite for delivery
of the granzymes, then free PFN should be more efficientsilver stain, approximately 10%–25% of the PFN re-
mained in the retentate, suggesting a stable interaction than PFN bound to SG. PFN-SG, on a molar basis, was
found to more effectively deliver GrB-SG as well as the(Figure 5A). Complex formation, however, was then di-
rectly verified by agarose gel electrophoresis of putative free granzyme (Figure 6B). Therefore, although PFN-SG
was significantly less membranolytic than free PFN, thePFN-SG complexes retrieved after membrane size ex-
clusion, followed by immunoblotting for PFN extracted complexed form displayed a similar or greater ability to
deliver the granzyme. Together the results indicate thatfrom bands containing SG (Figures 5B and 5C). When
the mobility of the preformed complexes was examined, PFN-SG appears to interact with target cells delivering
macromolecular granzyme through a process wherebywe failed to detect free PFN by protein stain, and the
SG band detected by toluidine blue stain appeared to membrane pore formation is not an obligatory step.
redistribute more broadly than SG alone (Figure 5B),
suggesting that an interaction with PFN reduced the Discussion
mobility of SG. The presence of PFN in the redistributed
SG band was then confirmed by agarose extraction and Evidence is presented that PFN functions in an unfore-
seen manner to deliver the physiologically relevant formanti-PFN immunoblotting (Figure 5C). Thereafter, the in-
fluence of increasing pH and Ca2 concentration on the of secreted GrB, a macromolecular complex of gran-
zyme and SG. We have proposed that granule-mediatedinteraction of PFN and SG was evaluated using chon-
droitin sulfate A (CS) coupled to Sepharose as surrogate. apoptosis is fundamentally a variant of virus-dependent
endocytosis where PFN facilitates delivery of internal-These results indicate (Figures 5D and 5E) that substan-
tial amounts of PFN remain complexed to CS-Sepharose ized granzyme (Froelich et al., 1998). We had shown that
target cells internalize membrane-bound granzyme andas pH and Ca2 are elevated to extracellular values. The
combined results indicate that both free and complexed speculated that delivery of the granzyme to the cytosol
was dependent on uptake of membrane remnants car-PFN are likely present extracellularly after granule exo-
cytosis and that both forms of PFN could contribute to rying PFN pores (Froelich et al., 1996a). The granule-
mediated cell death pathway appears, however, to sharethe delivery of the granzyme.
Since the interaction of PFN with glycosaminoglycans a greater similarity to viral-mediated cellular penetration
than initially anticipated. A macromolecular granulehas been reported to inhibit pore formation (Tschopp
and Masson, 1987), SG was also predicted to reduce complex consisting of granzyme, SG, and PFN analo-
gous to a viral particle may be the central effector. Thethis biologic activity, and the decreased membrane per-
meabilization mediated by PFN-SG would be associated granule-associated proteoglycan, SG, contributes to
granule-mediated apoptosis by acting as a carrier,with a reduction in the ability to deliver the granzyme.
We have observed that free PFN, averaging 5–20 ng/ which facilitates internalization of GrB and/or PFN. Ac-
Immunity
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Figure 4. GrB-SG Complexes—Stability, Proteolytic Properties, and Capacity to Induce Apoptosis after Intracellular Delivery
(A) Agarose gel electrophoresis of GrB-SG complexes. GrB (2.4g), SG (8.9g), and GrB-SG mixture underwent 1% agarose gel electrophoresis
followed by sequential toluidine blue and gel code blue staining. GrB alone migrates upward (negative electrode), while GrB in the GrB-SG
complex lane migrates along with SG.
(B) Anti-GrB immunoblotting of GrB-SG complexes extracted from agarose gel. Slabs were obtained from GrB and GrB-SG lanes as diagrammed
([A], boxes 1–3), extracted, and immunoblotted for anti-GrB. Stock GrB (125 ng) was positive control for blotting. GrB extracted from agarose
(GrB extract) was control for extraction efficiency. Slices corresponding to boxes 1, 2, and 3 from agarose gel contained putative GrB-SG
complexes (GrB-SG extract). Maximum signal for GrB colocalized to box 3, which migrated similarly to SG (see [A]). A substantial signal was
also associated with box 2. The signal below 32 kDa GrB band represents deglycosylated granzyme generated by alkaline hydrolysis during
extraction.
(C) Measurement of esterolytic activity of GrB/GrB-SG complex by BAADT assay. Free GrB and GrB-SG complex were incubated with substrate
and hydrolysis reported as mOD/min.
(D) GrB-SG is less efficient than free GrB in processing recombinant caspases-3 and -7 in vitro. Kinetics of proteolysis of caspase-3 (top, 500
nM) and -7 (bottom, 500 nM) were determined with either free GrB or GrB-SG (5 nM) for times indicated (min). At each time point, the reaction
was stopped by adding GrB inhibitor IETD-CHO (500 M), and the sample was electrophoresed and silver stained.
(E) GrB-SG delivered by AD efficiently induces apoptosis. Jurkat cells were treated with increasing concentrations of free or GrB-SG plus AD
for 4 hr. The percentage of apoptotic cells determined by TUNEL (mean  SD, n  3) was comparable to values observed by Hoescht (data
not shown).
(F) PFN-mediated delivery of free and GrB-SG. Jurkat cells were treated with GrB filtrate or GrB-SG (2 g/ml) and PFN stock (14 ng/ml) for
4 hr at 37C. The percentage of apoptotic cells by TUNEL (mean  SD, n  2) was comparable to values by Hoescht (data not shown).
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Figure 5. PFN Forms Stable Complexes with
SG In Vitro
(A) PFN-SG complexes exist at neutral pH
and isotonicity. PFN-SG complexes were
generated as described, and PFN complexed
to SG determined by subjecting 100 kDa re-
tentate and filtrate fractions to 10% SDS-
PAGE, silver stain, and densitometry. Ap-
proximately 10%–20% of PFN was retained
by 100 kDa membrane.
(B) Agarose gel electrophoresis of PFN-SG
complexes. PFN (2 g), SG (46.1 g), and
PFN-SG mixture underwent 1% agarose gel
electrophoresis and was stained to identify
PFN and SG. PFN alone migrates slightly up-
ward (negative electrode), while PFN in the
PFN-SG complex lane migrates with SG.
(C) Anti-PFN immunoblotting of PFN-SG ex-
tracted from agarose gel. Slabs were ob-
tained as diagrammed ([B], boxes 1–3), and
protein was extracted and immunoblotted
with anti-PFN. PFN (5 ng) served as immu-
noblot control, and extracts from slabs corre-
sponding to 1, 2, and 3 (PFN-SG extract) were
analyzed. Signal for PFN only colocalized to
box 3, which migrated similarly to SG (B).
(D) PFN remains associated with chondroitin
sulfate (CS) at neutral pH. PFN was mixed
with CS-Sepharose beads in buffers with de-
creasing pH as described ([pH 7.4, 7, 6, 5, and
4], lanes 2–6). Unbound PFN was removed
by centrifugation, and beads were washed
at room temperature with appropriate buffer.
The supernatant was subjected to 10% SDS-
PAGE, followed by silver stain and densitom-
etry. PFN alone (lane 1, 500 ng) served as
control. Approximately 65% of PFN remained
bound to CS-Sepharose at neutral pH, while
none was detectable in supernatant at pH 4.0.
(E) Calcium does not dissociate PFN from CS.
PFN was mixed with CS-Sepharose, and the
beads were washed and resuspended in the
same buffer containing increasing concentra-
tions of CaCl2 (0, 0.05, 0.2, 0.5, and 1.5 mM;
lanes 2–6, respectively). The beads were in-
cubated at room temperature for 10 min and
centrifuged. Both supernatant (free PFN) and
bead fractions (bound PFN) were subjected
to SDS-PAGE, silver stain, and densitometry.
PFN was not detectable in any of the superna-
tants.
cordingly, the killer cell is predicted to secrete the mac- granzyme, our inability to identify transiently expressed
pores on apoptotic target cells was unexpected. Theromolecular complex into the synapse-like space be-
tween effector and target cell. The complex then binds data, nevertheless, provide evidence that monomeric
PFN is internalized in a nonpore-forming state to facili-to the target cell and undergoes endocytosis. Within
the acidic vesicle, PFN alters the endocytic membrane, tate delivery of GrB. The results in Figure 1C are the first
to show that a target cell will ultimately die by apoptosisfacilitating release of the granzyme complex to the cyto-
sol. In support of this unexpected model, our primary without demonstrating signs of PFN-mediated mem-
brane damage. Second, using FM1-43 to monitor endo-observations include: (1) isolated PFN delivers GrB
through a process that does not require generation of cytic activity, the addition of PFN to targets induces
uptake of the dye without concomitant pore formationplasma membrane pores; (2) the macromolecular form
of GrB (i.e., GrB-SG) is secreted by cytotoxic cells, is (Kawasaki et al., 2000). Third, targets treated with a
combination of PFN and granzyme become apoptoticdelivered by PFN, and is potently apoptotic; and (3)
stable PFN-SG complexes also deliver this physiologic but continue to exclude low Mr dextran and protein fluo-
roprobes (Browne et al., 1999). Finally, target cells con-form of the granzyme.
Having predicted that plasma membrane pore forma- taining vesicle-associated granzyme (Pinkoski et al.,
1998) will undergo apoptosis when subsequently chal-tion is a crucial prerequisite for delivery of internalized
Immunity
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Figure 6. PFN-SG Complexes Deliver GrB-
SG without Plasma Membrane Permeabili-
zation
(A) Comparison of permeabilizing activity of
PFN and PFN-SG complexes. Jurkat cells
were treated with increasing concentrations
of stock PFN or PFN-SG for 30 min (37C),
and permeabilized cells were enumerated by
trypan blue stain. Results represent one of
four experiments.
(B) PFN-SG complexes can deliver GrB-SG
to induce apoptosis. Minimally permeabiliz-
ing concentrations (
20%) of PFN filtrate (66
ng/ml) or PFN-SG (30 ng/ml) were used in
combination with GrB-SG or free GrB (2 ug/
ml). The number of apoptotic events ob-
served by TUNEL (mean  SD, n  2) were
similar to results by Hoechst.
lenged with sublytic amounts of PFN (Froelich et al., to reduce PFN-dependent GrB-mediated cell death
(Browne et al., 1999), suggesting that PFN may act1996a).
PFN has been defined biologically by its ability to through a mechanism distinct from membrane pore for-
mation to deliver granzymes from intracellular vesicles.induce membrane permeabilization. However, at con-
centrations whereby permeabilization is virtually nonex- In this regard, the fusogenic properties of PFN could
disrupt the endosome in a manner analogous to suchistent, targets are rendered susceptible to an apoptotic
death if the granzyme is present. The 2-fold effect of PFN pore-forming proteins as listeriolysin. Studies are under-
way to learn whether the hydrophobic domain of PFN isreveals an alternate mechanism to explain the action
of the porin during granule-mediated apoptosis: PFN sufficient to disrupt endosomal membrane and whether
PFN acts alone or requires the presence of cofactorsmonomers (or oligomers) undergo internalization if the
target is exposed to a limited amount of the pore-form- such as SG for optimal membranolysis.
PFN was found to interact with SG in granules, sug-ing protein (Figure 1A). The results are consistent with
the collisional model of PFN pore formation (Peters et gesting that the pore-forming protein is secreted as a
complex and, after granule exocytosis, remains boundal., 1990) whereby PFN monomers bind to the plasma
membrane with insufficient proximity to form pores and and/or separates from the proteoglycan extracellularly.
We were unable to detect free or putative PFN-SG com-instead undergo clearance from the plasma membrane.
Since the interaction of PFN through its C2 domain with plexes after degranulation, in part because the Ca2
required for exocytosis inactivates PFN, making the pro-membrane-associated phosphorylcholine is considered
essential for binding (Uellner et al., 1997), the “phosphor- tein inaccessible to our immunoprecipitating antibody
(data not shown), and more likely due to the minusculeylcholine receptor” remains a plausible candidate to ini-
tiate either pore formation or internalization. Similar to amounts of PFN secreted by the effector cell, which
are below the detection limits of the antibodies used.certain viruses, PFN could generate channels in vesicu-
lar membranes, but the observation that plasma mem- Nevertheless, we establish here that isolated PFN does
form a stable complex with SG under extracellular condi-brane pores do not allow entry of GrB suggests that this
mechanism is unlikely. The pore-forming activity of PFN tions, supporting the concept that exocytosed PFN has
two molecular forms. Additional studies will be neces-is exquisitely pH dependent with an optimum near pH
7.0. Agents that alkalinize endosomes are reported sary to determine the proportion of free and bound PFN
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Figure 7. A Macromolecular Proapoptotic
Array Secreted by Cytotoxic Cells Induces
Death
Cytotoxic cells appear to secrete GrB on a
scaffold of SG. This macromolecular complex
will also contain PFN monomers and other
granzymes. Either GrB-SG-PFN or GrB-SG
and dissociated PFN monomer are then inter-
nalized. Regardless of the mechanism of PFN
uptake, the outcome is endosomolytic deliv-
ery of granule proteins.
secreted by cytotoxic cells and their relative contribu- and processing of putative substrates. To date, studies
utilizing the granzyme have employed the free cationiction to granzyme delivery. Importantly, SG used here
was monocytic in origin. We have recently isolated SG protease, which encourages nonspecific electrostatic
interactions with anionic membranes. This was a majorfrom NK cells, and preliminary studies indicate that YT-
SG is similar in nature to the THP-1 counterpart, forming concern when we reported that GrB was able to bind
to target cell in a receptor-dependent manner. The dis-stable complexes with GrB/PFN.
Although a caveat for comparing monomeric and covery that GrB uses the mannose-6-phosphate recep-
tor (MPR) for internalization suggested that the elusivecomplexed PFN is the inability to verify by an indepen-
dent technique that the two forms contain equivalent “GrB receptor” had been identified (Motyka et al., 2000).
However, on the basis of our observation that GrB isactive protein, our data suggest that PFN-SG more effi-
ciently delivers the granzyme. Paradoxically, monomeric secreted wrapped in anionic SG, other proteins are pre-
dicted to participate in the internalization of the gran-PFN was substantially more effective than PFN-SG in
permeabilizing targets. This dichotomy offers further zyme complex, particularly the CD44 family of isoforms,
which could focus or facilitate internalization of GrBsupport that the pore-forming and translocating activi-
ties may indeed be dissociated into separate mecha- through SG (Toyama-Sorimachi et al., 1995). The likeli-
hood that GrB-SG uses solely the MPR is also dimin-nisms. How SG modulates the action of PFN in this
delivery process is unclear. Since glycosaminoglycans ished by the observation that this trafficking system
targets the free enzyme. Detailed studies, therefore, areare reported to block the hemolytic activity of PFN, the
prevalent view is that proteoglycans are designed to necessary to examine the contribution of the MPR and
CD44 systems for endocytic uptake and trafficking ofinhibit PFN extracellularly. In light of the data here, the
interaction may serve to protect PFN from Ca-mediated granzymes. Although a single specific receptor for GrB
is attractive, to ensure elimination of target cells, GrBinactivation, allowing either internalization or focusing
of PFN monomers to exchange sites of the cell surface. should have the capacity to bind to multiple cell surface
structures. Our results are significant because the dataThe complexed form of PFN might therefore favor the
outcome of endosomolysis by encouraging uptake of provide a level of nonselectivity (i.e., degeneracy) for
GrB binding and internalization—a necessary prerequi-the pore-forming protein and reducing membrane per-
meabilization. site for killing. Specificity is ultimately endowed by the
effector cell recognition systems and complementedThe finding that GrB is secreted by cytotoxic cells
and delivered by PFN as a macromolecular complex has by secretion of PFN, which delivers the internalized
granzyme.enormous implications for the understanding of granule-
mediated apoptosis and forces reinterpretation of data Introducing monomeric GrB to the cytosol will result
in anomalous targeting of the granzyme to irrelevantfrom many laboratories. In comparison to the free gran-
zyme, the interaction of GrB with SG will alter cell surface cytosolic proteins. Consistent with this possibility, GrB-
SG was less efficient in processing caspase-3/-7 in vitro,binding characteristics, vesicular trafficking, and cyto-
solic movement, as well as the efficiency of targeting but the complex more effectively induced cell death.
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Experimental ProceduresAlthough the outcome may be due to enhanced effi-
ciency at multiple steps in the delivery process, we spec-
Reagentsulate that after release to the cytosol the complex is
L-glutamine, PMSF, leupeptin, aprotinin, EDTA, glycerol, parafor-
more appropriately targeted to the caspases, whereas maldehyde (PFA), 3-aminopropyltrietoxy-silane (APS), and propid-
free GrB would nonspecifically bind cytosolic proteins ium iodide were purchased from Sigma (St. Louis, MO), while RPMI
impairing this interaction. Postulated to represent alter- 1640 was from GIBCO. GELCODE blue stain reagent and Hoechst
33342 were, respectively, from Pierce (Rockford, IL) and Molecularnate or amplifying apoptotic pathways, GrB has been
Probes (Eugene, OR). Dynabead Protein-A and Apo-Direct kit were,reported to cleave cytosolic (BID, fibrillin) and, after
respectively, from Dynal (Lake Success, NY) and Pharmingen (Santranslocation, nuclear substrates (Andrade et al., 1998;
Diego, CA). The anti-G9 PFN mAb against native PFN and anti-PB2
Browne et al., 2000; Froelich et al., 1996b; Sutton et al., PFN mAb against central 199 AA span of PFN have been described
2000). Similarly, Bcl-2 overexpression partially inhibits (Hameed et al., 1992; Geisberg et al., 1990). Horseradish peroxidase
GrB-mediated death, but cytotoxic cell-induced apo- (HRP)-rat anti-mouse  mAb was from Accurate Chemical (West-
bury, NY), and ready gels, silver stain kit, Immunblot, and Sequiblot-ptosis is unaffected (Sutton et al., 1997). Studies will be
PVDF membranes were purchased from Bio-Rad (Hercules, CA),necessary to delineate the trafficking of GrB-SG after
while ECL Western blot system and Hyperfilm ECL were from Amer-intracellular delivery as well as the protein substrates
sham Pharmacia Biotech Inc. (Piscataway, NJ). [35S]Na2SO4 (specificcleaved by the granzyme complex. The tools are finally
activity 531.71 mC/mm) was from NEN Life Sciences (Boston, MA).
available to learn whether GrB induces cell death primar-
ily, if not solely, by activation of the caspase cascade,
Isolation of GrB, PFN, and SG
whether the granzyme retains the capacity to kill cells Human GrB and PFN were isolated as described (Hanna et al.,
independent of this death pathway, and how antiapo- 1993; Froelich et al., 1996c). Human serglycin was isolated from
supernatants of THP-1 and quantitated by Safranin O staining (Oyne-ptotic proteins such as Bcl-2 influence the intracellular
bra˚ten et al., 2000).behavior of GrB-SG.
Overall, our results indicate that PFN acts through two
Solubilization of Enriched Cytotoxic Granules and IPmechanisms in vitro: the commonly perceived capacity
Cells (YT, 2 	 106/ml) were incubated with [35S]Na2SO4 (25 uCi/ml)to perforate plasma membrane and the incompletely
for 20–24 hr, and cytotoxic granules isolated as described (Hannaunderstood process of endosomolysis. Although the
et al., 1993). The granules were solubilized with 0.5% Zwittergent
major determinant that predicts the cellular outcome in 3–12 in PBS overnight followed by preclearance and IP using either
vitro is the amount of PFN encountered by the target anti-GrB antibody (GB10) coupled to Sepharose (GB10-Sepharose;
(Figure 1A), it remains to be determined whether PFN Spaeny-Dekking et al., 1998), the anti-G9 PFN antibody (IgG2b, 20
g/ml), or, as a control, polyclonal anti-BSA antibody (30 g/ml).lyses cells in vivo. Numerous Cr release studies are
The latter two were incubated with Protein A-Dynal beads (4C over-interpreted to support the notion that PFN-mediated
night), and beads were washed and run on 4%–15% gradient gelsmembrane permeabilization is a common outcome.
under reducing conditions, followed by phosphoimaging.
However, these studies often do not distinguish Cr re-
lease due to PFN per se versus the response to the
IP and Western Blotting of Complexes from Cytotoxic Granules
apoptotic process. Isolated reports that examine targets Experiments that involved IP of GrB and PFN from in vivo complexes
for signs of PFN-mediated membrane damage in ef- in solubilized granules were executed as described above. To dem-
fector:target conjugates by CLSM do show that cyto- onstrate protein interactions, anti-GrB immunoprecipitated material
was probed with anti-PB2 PFN (1:1000) and vice versa (clone 2C5,toxic cells have the capacity to secrete PFN in amounts
1:10000) and developed with an anti-kappa HRP antibody (1:1000,sufficient to cause severe membrane damage, but these
Accurate Chemicals) and the ECL.studies do not assess the relative frequency of the pro-
cess (Oshimi et al., 1996). Recent single cell studies that
LAK Cell Generation and Granule Exocytosisexamine the morphological effects of CTL on targets
Lymphokine activated killer (LAK) cells were generated and inducedhave shown that membrane permeabilization is not a
to undergo exocytosis as described (Galvin et al., 1999). Superna-
customary early event but rather a late consequence of tants were collected, and degranulate was subjected to 100 kDa
CTL-mediated apoptosis (Hu and Kipps, 1999; Goldberg filtration (1000 g, 10 min). GrB ELISA was performed on the total
et al., 1999). These observations indicate that a CTL degranulate fraction, the 100 kDa retentate, and filtrate fractions.
normally may secrete sufficient PFN for endocytic up-
take but not membrane rupture. We suggest that a target Enzymatic Digestions of Proteoglycans
Cytotoxic granules from radiolabeled YT were solubilized with Zwit-cell interacts with a trimolecular complex consisting of
tergent 3–12 in PBS and immunoprecipitated with GB10-Sepharose.SG, PFN, and granzymes (likely both GrA and GrB). Fol-
Degranulates from radiolabeled LAK were fractionated on 100 kDalowing binding and internalization, granzyme-SG is re-
membrane, and retentate was subjected to GB10-Sepharose IP.leased to the cytosol by the endosomolytic action of The immunoprecipitated proteoglycans were then exposed to chon-
PFN. Equally plausible, after exocytosis into the cleft droitinase ABC (0.5 U/ml) (C ABC, Boehringer Mannheim, Indianapo-
between target and effector, PFN dissociates from the lis, IN) overnight (37C) or with heparinase or heparitinase (0.02 U/ml)
complex and acts separately to deliver the GrB-SG com- (Seikagaku Corp, Tokyo, Japan) overnight (43C). The beads were
then run on 4%–15% gradient gels (reduced) and phosphoimaged.plex in a process that does not appear to require pore
formation (Figure 7). Regardless of the mechanism, PFN
Generation and Analysis of GrB-SG and PFN-SG Complexesassuredly does not deliver the macromolecular gran-
GrB-SG complexes were prepared in GrB excess (3:1 w/w) whilezyme through transmembrane pores but rather from an
PFN-SG complexes were in SG excess (1:3 w/w) (150 mM NaCl andintracellular compartment. Granule-mediated apopto-
20 mM HEPES [pH 7.4]). Mixtures were chilled (20 min) and filtered
sis, therefore, should be viewed as a modular protein through Microcon YM-100 (100 kDa exclusion) (Millipore, Bedford,
delivery system whereby SG acts as a scaffold module, MA). GrB or PFN alone served as controls to assess duration of
PFN as the delivery module, and the granzymes as the filtration (GrB filtrate, PFN filtrate) whereby mixtures were spun until
controls lacked visible retentate. The concentrations of GrB andtargeting/informational module.
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PFN in retentates and filtrates were assessed by ELISA (GrB) and Imaging, Computers, and Software
Images of gels and immunoblots were captured either with a Kodaksilver staining/densitometry (PFN), respectively.
To confirm the stable interaction of GrB or PFN with SG, we digital camera or Saphir Ultra 2 flatbed scanner and exported to
Adobe Photoshop 6.0, after which the EPS images were placed forperformed agarose gel electrophoresis and immunoblotting of se-
lect bands. GrB-SG or PFN-SG were run on 1% agarose gels with final presentation in Adobe Illustrator 9.0 using a Macintosh Power
G4 computer.appropriate controls in Tris-Borate-EDTA (TBE) buffer. SG and pro-
teins were visualized by serial toluidine blue and gel code blue
staining. A set of proteoglycan standards (aggrecan, 2.5 	 103 Acknowledgments
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